 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 August 1997 | Volume 127 Issue 4 | Pages 267-274
Background: Central venous catheters are a principal source of nosocomial bloodstream infections, which are difficult to control.
Objective: To determine the efficacy of catheters coated with minocycline and rifampin in preventing catheter-related colonization and bloodstream infections.
Design: Multicenter, randomized clinical trial.
Setting: Five university-based medical centers.
Patients: 281 hospitalized patients who required 298 triple-lumen, polyurethane venous catheters.
Intervention: 147 catheters were pretreated with tridodecylmethyl-ammonium chloride and coated with minocycline and rifampin. Untreated, uncoated catheters (n = 151) were used as controls.
Measurements: Quantitative catheter cultures, blood cultures, and molecular typing of organisms to determine catheter-related colonization and bloodstream infections.
Results: The group with coated catheters and the group with uncoated catheters were similar with respect to age, sex, underlying diseases, degree of immunosuppression, therapeutic interventions, and risk factors for catheter infections. Colonization occurred in 36 (26%) uncoated catheters and 11 (8%) coated catheters (P < 0.001). Catheter-related bloodstream infection developed in 7 patients (5%) with uncoated catheters and no patients with coated catheters (P < 0.01). Multivariate logistic regression analysis showed that coating catheters with minocycline and rifampin was an independent protective factor against catheter-related colonization (P < 0.05). No adverse effects related to the coated catheters or antimicrobial resistance were seen. An estimate showed that the use of coated catheters could save costs.
Conclusions: Central venous catheters coated with minocycline and rifampin can significantly reduce the risk for catheter-related colonization and bloodstream infections. The use of these catheters may save costs.
Author and Article Information
The Texas Medical Center Catheter Study Group
ARTICLE
Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream Infections
A Randomized, Double-Blind Trial
From The University of Texas M.D. Anderson Cancer Center, Baylor College of Medicine Veterans Affairs Medical Center, Harris County Hospital District (Ben Taub General Hospital), The Methodist Hospital, and The University of Texas Health Science Center, Houston, Texas.
*For members of the Texas Medical Center Catheter Study Group, see Appendix.
Disclosure: Two patents are associated with the coated central venous catheter used in the study (catheters coated with minocycline and rifampin). The first patent, which describes the method of coating through the use of the cationic surfactant, is the property of the Robert Wood Johnson School of Medicine and Dentistry. Richard Harvey and Ralph Greco are the inventors. The second patent describes the synergistic and unique activity of the minocycline and rifampin combination in protecting catheter surfaces from slime-producing staphylococcal organisms. This patent is the property of The University of Texas M.D. Anderson Cancer Center and Baylor College of Medicine. Issam Raad and Rabih Darouiche (the first two authors of this article) are the inventors. Both patents were licensed by Cook Critical Care, with royalty rights to the Robert Wood Johnson School of Medicine and Dentistry, M.D. Anderson Cancer Center, and Baylor College of Medicine. The inventors receive a percentage of the royalties according to the royalty policies of each institution. None of the inventing senior authors have current links (such as stock ownership and service on a board or as a consultant) with Cook Critical Care or any other catheter company that might constitute a conflict of interest.
Grant Support: In part by a grant from The University Cancer Foundation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Catheters were supplied at no charge by Cook Critical Care, Bloomington, Indiana.
Requests for Reprints: Issam Raad, MD, Section of Infection Control, Box 47, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
Current Author Addresses: Drs. Raad, Dupuis, Abi-Said, Hachem, Buzaid, and Burke: The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Drs. Darouiche and Jones: Veterans Affairs Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  R. O. Darouiche In Vivo Efficacy of Antimicrobial-Coated Devices J. Bone Joint Surg. Am., August 1, 2008; 90(8): 1785 - 1786. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aslam and R. O. Darouiche Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters J. Antimicrob. Chemother., July 1, 2007; 60(1): 148 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Raad, H. Hanna, Y. Jiang, T. Dvorak, R. Reitzel, G. Chaiban, R. Sherertz, and R. Hachem Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1656 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Darouiche, M. D. Mansouri, D. Zakarevicz, A. AlSharif, and G. C. Landon In Vivo Efficacy of Antimicrobial-Coated Devices J. Bone Joint Surg. Am., April 1, 2007; 89(4): 792 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Falagas, K. Fragoulis, I. A. Bliziotis, and I. Chatzinikolaou Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials J. Antimicrob. Chemother., March 1, 2007; 59(3): 359 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hanna, P. Bahna, R. Reitzel, T. Dvorak, G. Chaiban, R. Hachem, and I. Raad Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3283 - 3288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Curtin and R. M. Donlan Using Bacteriophages To Reduce Formation of Catheter-Associated Biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1268 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abdelkefi, L. Torjman, S. Ladeb, T. Ben Othman, W. Achour, A. Lakhal, M. Hsairi, L. Kammoun, A. Ben Hassen, and A. B. Abdeladhim Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic Disease J. Clin. Oncol., November 1, 2005; 23(31): 7864 - 7870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Rupp, S. J. Lisco, P. A. Lipsett, T. M. Perl, K. Keating, J. M. Civetta, L. A. Mermel, D. Lee, E. P. Dellinger, M. Donahoe, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine on Central Catheter-Related Infections: A Randomized, Controlled Trial Ann Intern Med, October 18, 2005; 143(8): 570 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. McLean, C. J. Fisher, B. M. Snively, and A. R. Chauvenet Central Venous Lines in Children With Lesser Risk Acute Lymphoblastic Leukemia: Optimal Type and Timing of Placement J. Clin. Oncol., May 1, 2005; 23(13): 3024 - 3029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mohr, M. Peninger, and L. Ostrosky-Zeichner Infection Control in Intensive Care Units Journal of Pharmacy Practice, April 1, 2005; 18(2): 84 - 90. [Abstract] [PDF]
|
|
|
|
|
|
K. K. Haase, K. A. McCracken, and R. L. Akins Catheter-Related Bloodstream Infections in the Intensive Care Unit Population Journal of Pharmacy Practice, February 1, 2005; 18(1): 42 - 52. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Segarra-Newnham and E. M Martin-Cooper Antibiotic Lock Technique: A Review of the Literature Ann. Pharmacother., February 1, 2005; 39(2): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chaiban, H. Hanna, T. Dvorak, and I. Raad A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent J. Antimicrob. Chemother., January 1, 2005; 55(1): 51 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sedman, J. M. Harris II, K. Schulz, E. Schwalenstocker, D. Remus, M. Scanlon, and V. Bahl Relevance of the Agency for Healthcare Research and Quality Patient Safety Indicators for Children's Hospitals Pediatrics, January 1, 2005; 115(1): 135 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W L Jackson Jr, C Gallagher, R C Myhand, and J K Waselenko Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome Br. J. Radiol., January 1, 2005; Supplement_27(1): 161 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yucel, R. Lefering, M. Maegele, M. Max, R. Rossaint, A. Koch, R. Schwarz, M. Korenkov, J. Beuth, A. Bach, et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial J. Antimicrob. Chemother., December 1, 2004; 54(6): 1109 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Munson, S. O. Heard, and G. V. Doern In Vitro Exposure of Bacteria to Antimicrobial Impregnated-Central Venous Catheters Does Not Directly Lead to the Emergence of Antimicrobial Resistance Chest, November 1, 2004; 126(5): 1628 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hanna, R. Benjamin, I. Chatzinikolaou, B. Alakech, D. Richardson, P. Mansfield, T. Dvorak, M. F. Munsell, R. Darouiche, H. Kantarjian, et al. Long-Term Silicone Central Venous Catheters Impregnated With Minocycline and Rifampin Decrease Rates of Catheter-Related Bloodstream Infection in Cancer Patients: A Prospective Randomized Clinical Trial J. Clin. Oncol., August 1, 2004; 22(15): 3163 - 3171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kaufman and K. D. Fairchild Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants Clin. Microbiol. Rev., July 1, 2004; 17(3): 638 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Galloway and A. Bodenham Long-term central venous access Br. J. Anaesth., May 1, 2004; 92(5): 722 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Trautner and R. O. Darouiche Catheter-Associated Infections: Pathogenesis Affects Prevention Arch Intern Med, April 26, 2004; 164(8): 842 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Vandecasteele, W. E. Peetermans, A. Carbonez, and J. Van Eldere Metabolic Activity of Staphylococcus epidermidis Is High during Initial and Low during Late Experimental Foreign-Body Infection J. Bacteriol., April 15, 2004; 186(8): 2236 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Verso and G. Agnelli Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients J. Clin. Oncol., October 1, 2003; 21(19): 3665 - 3675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Bong, P Kite, M H Wilco, and M J McMahon Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial J. Clin. Pathol., October 1, 2003; 56(10): 731 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Prielipp and R. J. Sherertz Skin: The First Battlefield Anesth. Analg., October 1, 2003; 97(4): 933 - 935. [Full Text] [PDF]
|
|
|
|
|
|
H. A. Hanna, I. I. Raad, B. Hackett, S. K. Wallace, K. J. Price, D. E. Coyle, and C. L. Parmley Antibiotic-Impregnated Catheters Associated With Significant Decrease in Nosocomial and Multidrug-Resistant Bacteremias in Critically Ill Patients Chest, September 1, 2003; 124(3): 1030 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Shorr, C. W. Humphreys, and D. L. Helman New Choices for Central Venous Catheters: Potential Financial Implications Chest, July 1, 2003; 124(1): 275 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. McGee and M. K. Gould Preventing Complications of Central Venous Catheterization N. Engl. J. Med., March 20, 2003; 348(12): 1123 - 1133. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Lok, K. E. Stanley, J. E. Hux, R. Richardson, S. W. Tobe, and J. Conly Hemodialysis Infection Prevention with Polysporin Ointment J. Am. Soc. Nephrol., January 1, 2003; 14(1): 169 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. O'Grady, M. Alexander, E. P. Dellinger, J. L. Gerberding, S. O. Heard, D. G. Maki, H. Masur, R. D. McCormick, L. A. Mermel, M. L. Pearson, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections Pediatrics, November 1, 2002; 110(5): e51 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Hodge and J W L Puntis Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2002; 87(1): F21 - 24. [Full Text] [PDF]
|
|
|
|
|
|
I. I. Raad and H. A. Hanna Intravascular Catheter-Related Infections: New Horizons and Recent Advances Arch Intern Med, April 22, 2002; 162(8): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Darouiche, V. G. Fowler Jr., K. Adal, M. Kielhofner, D. Mansouri, and L. B. Reller Antimicrobial Activity of Prosthetic Heart Valve Sewing Cuffs Coated With Minocycline and Rifampin Antimicrob. Agents Chemother., February 1, 2002; 46(2): 543 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Eggimann and D. Pittet Infection Control in the ICU Chest, December 1, 2001; 120(6): 2059 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Merrer, B. De Jonghe, F. Golliot, J.-Y. Lefrant, B. Raffy, E. Barre, J.-P. Rigaud, D. Casciani, B. Misset, C. Bosquet, et al. Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients: A Randomized Controlled Trial JAMA, August 8, 2001; 286(6): 700 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Tcholakian and I. I. Raad Durability of Anti-Infective Effect of Long-Term Silicone Sheath Catheters Impregnated with Antimicrobial Agents Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1990 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bassetti, J. Hu, R. B. D'Agostino Jr., and R. J. Sherertz Prolonged Antimicrobial Activity of a Catheter Containing Chlorhexidine-Silver Sulfadiazine Extends Protection against Catheter Infections In Vivo Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1535 - 1538. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. B. Dimick, R. K. Pelz, R. Consunji, S. M. Swoboda, C. W. Hendrix, and P. A. Lipsett Increased Resource Use Associated With Catheter-Related Bloodstream Infection in the Surgical Intensive Care Unit Arch Surg, February 1, 2001; 136(2): 229 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Boelens, T. van der Poll, S. A. J. Zaat, J. L. A. N. Murk, J. J. Weening, and J. Dankert Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible to Staphylococcus epidermidis Biomaterial-Associated Infection than Are Wild-Type Mice Infect. Immun., December 1, 2000; 68(12): 6924 - 6931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Sherertz, E. W. Ely, D. M. Westbrook, K. S. Gledhill, S. A. Streed, B. Kiger, L. Flynn, S. Hayes, S. Strong, J. Cruz, et al. Education of Physicians-in-Training Can Decrease the Risk for Vascular Catheter Infection Ann Intern Med, April 18, 2000; 132(8): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Henrickson, R. A. Axtell, S. M. Hoover, S. M. Kuhn, J. Pritchett, S. C. Kehl, and J. P. Klein Prevention of Central Venous Catheter-Related Infections and Thrombotic Events in Immunocompromised Children by the Use of Vancomycin/Ciprofloxacin/Heparin Flush Solution: A Randomized, Multicenter, Double-Blind Trial J. Clin. Oncol., March 13, 2000; 18(6): 1269 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Marik Fever in the ICU Chest, March 1, 2000; 117(3): 855 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Davis and J. B. Porter Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta -thalassemia Blood, February 15, 2000; 95(4): 1229 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Carratalà, J. Niubó, A. Fernández-Sevilla, E. Juvé, X. Castellsagué, J. Berlanga, J. Liñares, and F. Gudiol Randomized, Double-Blind Trial of an Antibiotic-Lock Technique for Prevention of Gram-Positive Central Venous Catheter-Related Infection in Neutropenic Patients with Cancer Antimicrob. Agents Chemother., September 1, 1999; 43(9): 2200 - 2204. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. DIGIOVINE, C. CHENOWETH, C. WATTS, and M. HIGGINS The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care Unit Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 976 - 981. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. Veenstra, S. Saint, and S. D. Sullivan Cost-Effectiveness of Antiseptic-Impregnated Central Venous Catheters for the Prevention of Catheter-Related Bloodstream Infection JAMA, August 11, 1999; 282(6): 554 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. J. Elliott Role of antimicrobial central venous catheters for the prevention of associated infections J. Antimicrob. Chemother., April 1, 1999; 43(4): 441 - 446. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Veenstra, S. Saint, S. Saha, T. Lumley, and S. D. Sullivan Efficacy of Antiseptic-Impregnated Central Venous Catheters in Preventing Catheter-Related Bloodstream Infection: A Meta-analysis JAMA, January 20, 1999; 281(3): 261 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Darouiche, I. I. Raad, S. O. Heard, J. I. Thornby, O. C. Wenker, A. Gabrielli, J. Berg, N. Khardori, H. Hanna, R. Hachem, et al. A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters N. Engl. J. Med., January 7, 1999; 340(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, X. Zhang, and R. Whitbourne In Vitro Antimicrobial Activity of a New Antiseptic Central Venous Catheter J Biomater Appl, January 1, 1999; 13(3): 206 - 223. [Abstract] [PDF]
|
|
|
|
|
|
R. O. DAROUICHE, J. FARMER, C. CHAPUT, M. MANSOURI, G. SALEH, and G. C. LANDON Anti-Infective Efficacy of Antiseptic-Coated Intramedullary Nails*{{dagger}} J. Bone Joint Surg. Am., September 1, 1998; 80(9): 1336 - 1340. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bach and S. D. Tennenberg A Randomized Trial of an Antibiotic- and Antiseptic-Coated Central Venous Catheter in the Prevention of Catheter-Related Infections Arch Surg, September 1, 1998; 133(9): 1022 - 1022. [Full Text] [PDF]
|
|
|
|
 |
|
 PREVENTION OF CATHETER-RELATED BLOODSTREAM INFECTION Journal Watch (General), August 29, 1997; 1997(829): 5 - 5. [Full Text]
|
|
Article
